Rituxan Hycela 1,400 mg/23,400 Units injection for subcutaneous use Images
Generic Name: hyaluronidase/rituximab
This medication has been identified as Rituxan Hycela 1,400 mg/23,400 Units injection for subcutaneous use. It is supplied by Genentech, Inc.
Rituxan Hycela is used in the treatment of Diffuse Large B-Cell Lymphoma; Chronic Lymphocytic Leukemia; Follicular Lymphoma and belongs to the drug class CD20 monoclonal antibodies. Rituxan Hycela 1,400 mg/23,400 Units injection for subcutaneous use is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Rituxan Hycela
- Generic Name
- hyaluronidase/rituximab
- Strength
- 1,400 mg/23,400 Units injection for subcutaneous use
- Availability
- Prescription only
- Drug Class
- CD20 monoclonal antibodies
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0108
See also:
More about Rituxan Hycela (hyaluronidase / rituximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.